COLUMBIA LABORATORIES INC
NT 10-K, 1995-03-31
PHARMACEUTICAL PREPARATIONS
Previous: HARTFORD LIFE INS CO PUTMAN CAPITAL MGR TR SEPARATE ACCOUNT, 497, 1995-03-31
Next: MANHATTAN BEACH HOTEL PARTNERS LP, 10-K, 1995-03-31



                                 UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549
                                  FORM 12B-25
                          NOTIFICATION OF LATE FILING
                                   FORM 10-K
                  FOR THE FISCAL YEAR ENDED DECEMBER 31, 1994
 
PART I--REGISTRANT INFORMATION
 
Columbia Laboratories, Inc.
2665 South Bayshore Drive
Miami, Florida 33133
 
PART II--RULES 12B-25(B) AND (C)
 
     The reasons described in Part III of this form could not be eliminated
without unreasonable effort or expense. The subject annual report on Form 10-K
will be filed on or before April 17, 1995.
 
PART III--NARRATIVE
 
     The Company was not able to complete the preparation of the Form 10-K on a
timely basis because the Company has been devoting a significant amount of its
time and resources towards negotiations in respect of a transaction which
management believes will have a significant impact on the Company, including its
current financial position.
 
PART IV--OTHER INFORMATION
 
(1) Margaret J. Roell
    Vice President--Finance and Administration
    Chief Financial Officer
    (305) 860-1670
 
(2) Yes
 
(3) No
 
     Columbia Laboratories, Inc. has caused this notification to be signed on
its behalf by the undersigned hereunto duly authorized.
 
                                          /s/_Margaret J. Roell_________________
                                          Vice President--Finance and
                                          Administration
                                          Chief Financial Officer
 
Dated March 30, 1995




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission